Effects of propofol on functional activities of hepatic and extrahepatic conjugation enzyme systems

British Journal of Anaesthesia

Volumn 84, Issue 6, 2000, Pages 771-776

  Chen, T L ^a   Wu, C H ^a   Chen, T G ^a   Tai, Y T ^a   Chang, H C ^a   Lin, C J ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Anaesthetics i.v., propofol; Enzymes; Liver, microsomes

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; 1 NAPHTHOL; 4 AMINOBENZOIC ACID; ACYLTRANSFERASE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; LIVER ENZYME; PROPOFOL;

ADULT; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME SUBSTRATE; FEMALE; HAMSTER; HUMAN; HUMAN TISSUE; INTESTINE; KIDNEY MICROSOME; LIVER CYTOSOL; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034023868     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bja.a013592     Document Type: Article

References (42)

1. Guengerich FP. Reaction and significance of cytochrome P-450 enzymes. J Biol Chem 1991; 266: 10019-22
2. Pacifici GM, Franchi M, Bencini C, Repetti F, Lascio ND, Muraro GB. Tissue distribution of drug-metabolizing enzyme in humans. Xenobiotica 1988; 18: 849-56
3. Gram TE, Okine LK, Gram RA. The metabolism of xenobiotics by certain extrahepatic organs and its relation to toxicity. Annu Rev Pharmacol Toxicol 1986; 26: 259-91
4. Tephly TR, Green MD, Coffman BL, King C, Cheng Z, Rios GR. Metabolism of endobiotics and xenobiotics by UDP-glucuronosyltransferase. Adv Pharmacol 1998; 42: 343-6
5. Hayes PC, Bouchier IAD, Beckett GJ. Glutathione S-transferase in humans in health and disease. Gut 1991; 32: 813-8
6. Levy M, Caraco Y, Geisslinger G. Drug acetylation in liver disease. Clin Pharmacokinet 1998; 34: 219-26
7. Coffman BL, Rios GR, Tephly TR. Purification and properties of two rat liver phenobarbital-inducible UDP-glucurono-syltransferases that catalyzes the glucuronidation of opioids. Drug Metoh Dispos 1996; 24: 329-33
8. Gerkens JF, Desmond PV, Schenker S, Branch RA. Hepatic and extrahepatic glucuronidation of lorazepam in the dog. Hepatology 1981; 1: 329-35
9. Hoyumpa AM, Schenker S. Is glucuronidation truly preserved in patients with liver disease? Hepotology 1991; 13: 786-95
10. Strasser SI, Mashford ML, Desmond PV. Regulation of uridine diphosphate glucuronosyltransferase during the acute-phase response. J Gostroen Hepatol 1998; 13: 88-94
11. Zaphiropoulos PG, Mode A, Norstedt G, Gustaffson JA. Regulation of sexual differentiation in drug and steroid metabolism. Trends Pharmacol Sci 1989; 10: 149-53
12. Wynne HA, James OFW. The aging liver. Age Ageing 1990; 19: 1-3
13. Hoyumpa AM, Schenker S. Major drug interactions: effect of liver disease, alcohol and malnutrition. Annu Rev Med 1983; 33: 113-49
14. Deegan RJ. Propofol: a review of the pharmacology and applications of an intravenous anesthetic agent. Am J Med Sci 1992; 304: 45-9
15. Bailie GR, Cockshott ID, Douglas EJ, Bowles BJM. Pharmacokinetics of propofol during and after long term continuous infusion for maintenance of sedation in ICU patients. Br J Anaesth 1992; 68: 486-91
16. Janicki PK, James MFM, Erskine WAR. Propofol inhibits enzymatic degradation of alfentanil and sufentanil by isolated liver microsomes in vitro. Br J Anaesth 1992; 68: 311-2
17. Baker MT, Chadam MV, Ronnenberg WC Jr. Inhibitory effects of propofol on cytochrome P450 activities in rat hepatic microsomes. Anesth Analg 1993; 76: 817-21
18. Chen TL, Ueng TH, Chen SH, Lee PH, Fan SZ, Liu CC. Human cytochrome P450 monooxygenase system is suppressed by propofol. Br J Anaesth 1995; 74: 558-62
19. Tiainen P, Lindgren L, Rosenberg PH. Disturbance of hepatocellular integrity associated with propofol anaesthesia in surgical patients. Acta Anaesthesiol Scand 1995; 39: 840-4
20. Motsch J, Schmidt H, Bach A, Bottiger BW, Bohrer H. Long-term sedation with propofol and green discolouration of the liver. Eur J Anaesth 1994; 11: 499-502
21. Alvares AP, Mannering GJ. Two-substrate kinetics of drug-metabolizing enzyme systems of hepatic microsomes. Mol Pharmacol 1970; 6: 206-11
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-75
23. Mackenzie PI, Hanninen O. A sensitive kinetics assay for UDP-glucuronosyltransferase using I-naphthol as substrate. Anal Biochem 1980; 109: 362-8
24. Habig WH, Pabst MJ, Jacoby WB. Glutathione S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-9
25. Anders HH, Klem AJ, Szabo SM, Weber WW. New spectrophotometric and radiochemical assays for acetyl-CoA: arylamine N-acetyltransferase applicable to a variety of arylamines. Anal Biochem 1985; 145: 367-75
26. Hussey AJ, Howie J, Allan LG, Drummond G, Hayes JD, Beckett GJ. Impaired hepatocellular integrity during general anaesthesia, as assessed by measurement of plasma glutathione S-transferase. Clin Chim Acta 1986; 161: 19-28
27. Kantos J, Gepts E. Pharmacokinetic implications for the clinical use of propofol. Clin Pharmacol 1989; 17: 308-26
28. Lange H, Stephan H, Rieke H, Kellermann M, Sonntag H, Bircher J. Hepatic and extrahepatic disposition of propofol in patients undergoing coronary bypass surgery. Br J Anaesth 1990; 64: 563-70
29. Chen TL, Wang MJ, Huang CH, Liu CC, Ueng TH. Difference between in vivo and in vitro effects of propofol on defluorination and metabolic activities of hamster hepatic cytochrome P450-dependent mono-oxygenases. Br J Anaesth 1995; 75: 462-6
30. King C, Green MD, Rios GR, et al. The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase I.I. Arch Biochem Biophys 1996; 232: 92-100
31. Mackenzie PI, Owen IS, Burchell B, et al. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 1997; 7: 255-69
32. Singh OMP, Graham AB, Wood GC. The phospholipid dependence of UDP-glucuronosyltransferase: conformation/reactivity studies with purified enzyme. Biochem Biophys Res Commun 1982; 107: 345-9
33. Mannervik B. The isoenzymes of glutathione transferase. Enzymol Relat Areas Mol Biol 1980; 57: 357-417
34. Wolkoff AW. The glutathione S-trarsferases: their role in the transport of organic anions from blood to bile. Int Rev Physiol 1980; 21: 151-69
35. Mulder TPJ, Janssens AR, de Bruin WCC, Peters WHM, Cooreman MP, Jansen JBMJ. Plasma glutathione S-transferase alpha-1 levels in patients with chronic liver disorders. Clin Chim Acta 1997; 258: 69-77
36. Beckett GJ, Chapman BJ, Dyson EH, Hayes JD. Plasma glutathione S-transferase measurements after paracetamol overdose: evidence for early hepatocellular damage. Gut 1985; 26: 26-31
37. Singh SV, Leal T, Awasthi Y. Inhibition of human glutathione S-transferase by bile acids. Toxicol Appl Pharmacol 1980; 95: 248-54
38. Hayes PC, Harrison DJ, Bouchier IAD, McLellan LI, Hayes JD. Cytosolic and microsomal glutathione S-transferase isoenzymes in normal human liver and intestinal epithelium. Gut 1989; 30: 854-9
39. Weber WW, Hein DW. N-acetylation pharmacogenetics. Pharmacol Rev 1985; 37: 25-79
40. Claeys MA, Gepts E, Camu F. Haemodynamic changes during anaesthesia and maintained with propofol. Br J Anaesth 1988; 60: 3-9
41. Runciman WB, Mather LE, Selby DG. Cardiovascular effects of propofol and of thiopentone anaesthesia in the sheep. Br J Anaesth 1990; 65: 353-9
42. Perry SM, Whelan E, Shay S, Wood AJJ, Wood M. Effects of i.v. anaesthesia with propofol on drug distribution and metabolism in the dog. Br J Anaesth 1991; 66: 66-72